Oxaliplatin-Based Platinum(IV) Prodrug Bearing Toll-like Receptor 7 Agonist for Enhanced Immunochemotherapy

[Image: see text] A combination of platinum drugs with immunotherapy has shown promising anticancer effects, especially in the drug resistance cancer model. Herein, a new type of immunochemotherapeutic was designed by tethering the toll-like receptor 7 (TLR7) agonist on the axial position of oxalipl...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Li, Cai, Demin, Qin, Mian, Lu, Shuo, Hu, Ming-Hao, Ruan, Shuangchen, Jin, Guangyi, Wang, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964279/
https://www.ncbi.nlm.nih.gov/pubmed/31956823
http://dx.doi.org/10.1021/acsomega.9b03381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964279/
https://www.ncbi.nlm.nih.gov/pubmed/31956823
http://dx.doi.org/10.1021/acsomega.9b03381

Ejemplares similares